Safety of sugammadex for
reversal of neuromuscular block: a post-marketing study based on the
World Health Organization pharmacovigilance database
Running title: Sugammadex safety for block reversal
Qiang Lyu1,2†, Pei Ye3†, Hewei
Zhang4†, Xiaofei Ye4, Yi
Zheng4, Jinfang Xu4, Xiao
Chen4, Chenxin Chen4, Xiaojing
Guo4*
1Basic Medical College, Naval Medical University,
Shanghai, China.
292608 Militang Hospital of PLA, Shanghai, China
3Department of Anaesthesiology, Huadong Hospital
Affiliated to Fudan University, Shanghai, China
4Department of Health Statistics, Faculty of Health
Service, Naval Medical University, Shanghai, China
†Qiang Lyu, Pei Ye, and Hewei Zhang contributed
equally to this work.
*Correspondence: guoxiaojing1003@163.com